
### [MONDO:0000634](http://purl.obolibrary.org/obo/MONDO_0000634)
**Label:** thoracic benign neoplasm

**Subclasses:** [MONDO:0015871](http://purl.obolibrary.org/obo/MONDO_0015871) (benign breast phyllodes tumor), [MONDO:0003726](http://purl.obolibrary.org/obo/MONDO_0003726) (apocrine adenosis of breast), [MONDO:0000971](http://purl.obolibrary.org/obo/MONDO_0000971) (chest wall lipoma), [MONDO:0003723](http://purl.obolibrary.org/obo/MONDO_0003723) (blunt duct adenosis of breast), [MONDO:0003724](http://purl.obolibrary.org/obo/MONDO_0003724) (non-proliferative fibrocystic change of the breast), [MONDO:0000974](http://purl.obolibrary.org/obo/MONDO_0000974) (axillary lipoma), [MONDO:0021514](http://purl.obolibrary.org/obo/MONDO_0021514) (benign neoplasm of pericardium), [MONDO:0006118](http://purl.obolibrary.org/obo/MONDO_0006118) (breast fibrosis), [MONDO:0003840](http://purl.obolibrary.org/obo/MONDO_0003840) (epicardium lipoma), [MONDO:0003841](http://purl.obolibrary.org/obo/MONDO_0003841) (heart lipoma), [MONDO:0003126](http://purl.obolibrary.org/obo/MONDO_0003126) (breast hemangioma), [MONDO:0004531](http://purl.obolibrary.org/obo/MONDO_0004531) (sclerosing adenosis of breast), [MONDO:0000970](http://purl.obolibrary.org/obo/MONDO_0000970) (breast lipoma), [MONDO:0003284](http://purl.obolibrary.org/obo/MONDO_0003284) (mediastinum leiomyoma), [MONDO:0006278](http://purl.obolibrary.org/obo/MONDO_0006278) (lung papilloma), [MONDO:0004253](http://purl.obolibrary.org/obo/MONDO_0004253) (intraductal breast papillomatosis), [MONDO:0021505](http://purl.obolibrary.org/obo/MONDO_0021505) (benign neoplasm of endocardium), [MONDO:0021508](http://purl.obolibrary.org/obo/MONDO_0021508) (benign neoplasm of epicardium), [MONDO:0021509](http://purl.obolibrary.org/obo/MONDO_0021509) (benign neoplasm of myocardium), [MONDO:0004827](http://purl.obolibrary.org/obo/MONDO_0004827) (esophagus squamous cell papilloma), [MONDO:0004506](http://purl.obolibrary.org/obo/MONDO_0004506) (microscopic breast papilloma), [MONDO:0021301](http://purl.obolibrary.org/obo/MONDO_0021301) (adenoma of nipple), [MONDO:0004507](http://purl.obolibrary.org/obo/MONDO_0004507) (atypical breast papilloma), [MONDO:0004428](http://purl.obolibrary.org/obo/MONDO_0004428) (alveoli adenoma), [MONDO:0000620](http://purl.obolibrary.org/obo/MONDO_0000620) (breast benign neoplasm), [MONDO:0004505](http://purl.obolibrary.org/obo/MONDO_0004505) (central breast papilloma), [MONDO:0003897](http://purl.obolibrary.org/obo/MONDO_0003897) (breast epithelioid hemangioma), [MONDO:0003896](http://purl.obolibrary.org/obo/MONDO_0003896) (breast capillary hemangioma), [MONDO:0004421](http://purl.obolibrary.org/obo/MONDO_0004421) (sclerosing breast papilloma), [MONDO:0003254](http://purl.obolibrary.org/obo/MONDO_0003254) (cardiac granular cell neoplasm), [MONDO:0007893](http://purl.obolibrary.org/obo/MONDO_0007893) (Noonan syndrome with multiple lentigines), [MONDO:0011500](http://purl.obolibrary.org/obo/MONDO_0011500) (Becker nevus syndrome), [MONDO:0003294](http://purl.obolibrary.org/obo/MONDO_0003294) (pericardium leiomyoma), [MONDO:0003293](http://purl.obolibrary.org/obo/MONDO_0003293) (lung leiomyoma), [MONDO:0013688](http://purl.obolibrary.org/obo/MONDO_0013688) (linear and whorled nevoid hypermelanosis), [MONDO:0021531](http://purl.obolibrary.org/obo/MONDO_0021531) (fibroma of lung), [MONDO:0001009](http://purl.obolibrary.org/obo/MONDO_0001009) (solitary cyst of breast), [MONDO:0009930](http://purl.obolibrary.org/obo/MONDO_0009930) (pulmonary arteriovenous malformation (disease)), [MONDO:0021456](http://purl.obolibrary.org/obo/MONDO_0021456) (benign neoplasm of sternum), [MONDO:0002732](http://purl.obolibrary.org/obo/MONDO_0002732) (lung benign neoplasm), [MONDO:0003944](http://purl.obolibrary.org/obo/MONDO_0003944) (endobronchial leiomyoma), [MONDO:0003427](http://purl.obolibrary.org/obo/MONDO_0003427) (bronchus adenoma), [MONDO:0004832](http://purl.obolibrary.org/obo/MONDO_0004832) (esophagus leiomyoma), [MONDO:0006934](http://purl.obolibrary.org/obo/MONDO_0006934) (pulmonary sclerosing hemangioma), [MONDO:0021459](http://purl.obolibrary.org/obo/MONDO_0021459) (benign neoplasm of esophagus), [MONDO:0003422](http://purl.obolibrary.org/obo/MONDO_0003422) (lung adenoma), [MONDO:0002057](http://purl.obolibrary.org/obo/MONDO_0002057) (breast leiomyoma), [MONDO:0002056](http://purl.obolibrary.org/obo/MONDO_0002056) (breast fibroadenoma), [MONDO:0006931](http://purl.obolibrary.org/obo/MONDO_0006931) (pulmonary coin lesion), [MONDO:0002058](http://purl.obolibrary.org/obo/MONDO_0002058) (breast adenoma), [MONDO:0002377](http://purl.obolibrary.org/obo/MONDO_0002377) (breast intracanalicular fibroadenoma), [MONDO:0021450](http://purl.obolibrary.org/obo/MONDO_0021450) (benign neoplasm of heart), [MONDO:0004397](http://purl.obolibrary.org/obo/MONDO_0004397) (benign mediastinal psammomatous neurilemmoma), [MONDO:0004398](http://purl.obolibrary.org/obo/MONDO_0004398) (mediastinal schwannoma), [MONDO:0002371](http://purl.obolibrary.org/obo/MONDO_0002371) (breast pericanalicular fibroadenoma), [MONDO:0004079](http://purl.obolibrary.org/obo/MONDO_0004079) (bronchial mucus gland adenoma), [MONDO:0021097](http://purl.obolibrary.org/obo/MONDO_0021097) (intraductal breast papilloma), [MONDO:0002055](http://purl.obolibrary.org/obo/MONDO_0002055) (benign eccrine breast spiradenoma), [MONDO:0004273](http://purl.obolibrary.org/obo/MONDO_0004273) (breast apocrine adenoma), [MONDO:0004270](http://purl.obolibrary.org/obo/MONDO_0004270) (breast ductal adenoma), [MONDO:0004150](http://purl.obolibrary.org/obo/MONDO_0004150) (breast giant fibroadenoma), [MONDO:0004271](http://purl.obolibrary.org/obo/MONDO_0004271) (pregnancy adenoma), [MONDO:0021528](http://purl.obolibrary.org/obo/MONDO_0021528) (benign neoplasm of male breast), [MONDO:0012691](http://purl.obolibrary.org/obo/MONDO_0012691) (leopard syndrome 2), [MONDO:0021529](http://purl.obolibrary.org/obo/MONDO_0021529) (benign neoplasm of chest wall), [MONDO:0004808](http://purl.obolibrary.org/obo/MONDO_0004808) (benign mammary dysplasia), [MONDO:0003637](http://purl.obolibrary.org/obo/MONDO_0003637) (lung clear cell-sugar-tumor), [MONDO:0013380](http://purl.obolibrary.org/obo/MONDO_0013380) (leopard syndrome 3), [MONDO:0021521](http://purl.obolibrary.org/obo/MONDO_0021521) (benign neoplasm of mediastinum), [MONDO:0005219](http://purl.obolibrary.org/obo/MONDO_0005219) (breast fibrocystic disease), [MONDO:0003955](http://purl.obolibrary.org/obo/MONDO_0003955) (juvenile breast papillomatosis), [MONDO:0000963](http://purl.obolibrary.org/obo/MONDO_0000963) (esophageal lipoma), [MONDO:0001012](http://purl.obolibrary.org/obo/MONDO_0001012) (breast fibroadenosis), [MONDO:0002585](http://purl.obolibrary.org/obo/MONDO_0002585) (proliferative type fibrocystic change of breast), [MONDO:0001011](http://purl.obolibrary.org/obo/MONDO_0001011) (breast cyst), [MONDO:0001099](http://purl.obolibrary.org/obo/MONDO_0001099) (lactocele), [MONDO:0001013](http://purl.obolibrary.org/obo/MONDO_0001013) (fibrosclerosis of breast), [MONDO:0002388](http://purl.obolibrary.org/obo/MONDO_0002388) (intracystic papillary adenoma), [MONDO:0002063](http://purl.obolibrary.org/obo/MONDO_0002063) (breast papillomatosis), [MONDO:0002065](http://purl.obolibrary.org/obo/MONDO_0002065) (benign breast adenomyoepithelioma), [MONDO:0002062](http://purl.obolibrary.org/obo/MONDO_0002062) (breast myofibroblastoma), [MONDO:0003194](http://purl.obolibrary.org/obo/MONDO_0003194) (hemangioma of lung), 

**Mapped go classes:** [GO:0005070](http://purl.obolibrary.org/obo/GO_0005070) (SH3/SH2 adaptor activity), [GO:0050839](http://purl.obolibrary.org/obo/GO_0050839) (cell adhesion molecule binding), [GO:0060125](http://purl.obolibrary.org/obo/GO_0060125) (negative regulation of growth hormone secretion), [GO:0000187](http://purl.obolibrary.org/obo/GO_0000187) (activation of MAPK activity), [GO:0000186](http://purl.obolibrary.org/obo/GO_0000186) (activation of MAPKK activity), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0009967](http://purl.obolibrary.org/obo/GO_0009967) (positive regulation of signal transduction), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0045931](http://purl.obolibrary.org/obo/GO_0045931) (positive regulation of mitotic cell cycle), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0048011](http://purl.obolibrary.org/obo/GO_0048011) (neurotrophin TRK receptor signaling pathway), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0004709](http://purl.obolibrary.org/obo/GO_0004709) (MAP kinase kinase kinase activity), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0035265](http://purl.obolibrary.org/obo/GO_0035265) (organ growth), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0060020](http://purl.obolibrary.org/obo/GO_0060020) (Bergmann glial cell differentiation), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0005057](http://purl.obolibrary.org/obo/GO_0005057) (signal transducer activity, downstream of receptor), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0060028](http://purl.obolibrary.org/obo/GO_0060028) (convergent extension involved in axis elongation), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding), [GO:0038127](http://purl.obolibrary.org/obo/GO_0038127) (ERBB signaling pathway), [GO:0061582](http://purl.obolibrary.org/obo/GO_0061582) (intestinal epithelial cell migration), [GO:0046887](http://purl.obolibrary.org/obo/GO_0046887) (positive regulation of hormone secretion), [GO:0043254](http://purl.obolibrary.org/obo/GO_0043254) (regulation of protein complex assembly), [GO:0042445](http://purl.obolibrary.org/obo/GO_0042445) (hormone metabolic process), [GO:0046888](http://purl.obolibrary.org/obo/GO_0046888) (negative regulation of hormone secretion), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0033629](http://purl.obolibrary.org/obo/GO_0033629) (negative regulation of cell adhesion mediated by integrin), [GO:0033628](http://purl.obolibrary.org/obo/GO_0033628) (regulation of cell adhesion mediated by integrin), [GO:0071260](http://purl.obolibrary.org/obo/GO_0071260) (cellular response to mechanical stimulus), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0007173](http://purl.obolibrary.org/obo/GO_0007173) (epidermal growth factor receptor signaling pathway), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0009755](http://purl.obolibrary.org/obo/GO_0009755) (hormone-mediated signaling pathway), [GO:0032528](http://purl.obolibrary.org/obo/GO_0032528) (microvillus organization), [GO:0043274](http://purl.obolibrary.org/obo/GO_0043274) (phospholipase binding), [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0031434](http://purl.obolibrary.org/obo/GO_0031434) (mitogen-activated protein kinase kinase binding), [GO:0048609](http://purl.obolibrary.org/obo/GO_0048609) (multicellular organismal reproductive process), [GO:0046825](http://purl.obolibrary.org/obo/GO_0046825) (regulation of protein export from nucleus), [GO:0003146](http://purl.obolibrary.org/obo/GO_0003146) (heart jogging), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:2001275](http://purl.obolibrary.org/obo/GO_2001275) (positive regulation of glucose import in response to insulin stimulus), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0046676](http://purl.obolibrary.org/obo/GO_0046676) (negative regulation of insulin secretion), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0021697](http://purl.obolibrary.org/obo/GO_0021697) (cerebellar cortex formation), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0009968](http://purl.obolibrary.org/obo/GO_0009968) (negative regulation of signal transduction), [GO:0051463](http://purl.obolibrary.org/obo/GO_0051463) (negative regulation of cortisol secretion), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0035855](http://purl.obolibrary.org/obo/GO_0035855) (megakaryocyte development), [GO:0033277](http://purl.obolibrary.org/obo/GO_0033277) (abortive mitotic cell cycle), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0036302](http://purl.obolibrary.org/obo/GO_0036302) (atrioventricular canal development), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0004726](http://purl.obolibrary.org/obo/GO_0004726) (non-membrane spanning protein tyrosine phosphatase activity), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.44%
- [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus) 51.72%
- [GO:0071260](http://purl.obolibrary.org/obo/GO_0071260) (cellular response to mechanical stimulus) 51.72%
- [GO:0070849](http://purl.obolibrary.org/obo/GO_0070849) (response to epidermal growth factor) 51.72%
- [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis) 51.72%
- [GO:0060020](http://purl.obolibrary.org/obo/GO_0060020) (Bergmann glial cell differentiation) 51.72%
- [GO:0048708](http://purl.obolibrary.org/obo/GO_0048708) (astrocyte differentiation) 51.72%
- [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis) 51.72%
- [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway) 51.72%
- [GO:0048011](http://purl.obolibrary.org/obo/GO_0048011) (neurotrophin TRK receptor signaling pathway) 51.72%
- [GO:0036302](http://purl.obolibrary.org/obo/GO_0036302) (atrioventricular canal development) 51.72%
- [GO:0035855](http://purl.obolibrary.org/obo/GO_0035855) (megakaryocyte development) 51.72%
- [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth) 51.72%
- [GO:0033277](http://purl.obolibrary.org/obo/GO_0033277) (abortive mitotic cell cycle) 51.72%
- [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation) 51.72%


